The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic ...

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

In a highly unusual move for a normally buttoned-up regulatory agency, a senior official with the US Food and Drug Administration held a call with reporters Thursday to defend the agency’s recent ...

The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to antidepressants about unproven ...

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

The U.S. Food and Drug Administration's (FDA) chief says the agency will begin offering bonuses to drug reviewers who ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

Add Yahoo as a preferred source to see more of our stories on Google. Nitrosamines are by-products of many common chemical reactions. FatCamera/iStock via Getty Images Plus A generic blood pressure ...

The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has grappled with how to handle new vaccine guidance. The agency has changed — five ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency.